Print Page   |   Contact Us   |   Sign In   |   Join Now
News & Press: Members in the News

Dr. Jonathan Baell Awarded Grant for Neglected Disease Research

Friday, August 1, 2014   (0 Comments)
Posted by: Heather Fineman
Share |
ICBS is pleased to recognize board member, Dr. Jonathan Baell, who has been successful in an application to the GSK Tres Cantos Open Lab Foundation for a project titled, “Hit to Lead Optimization for kinetoplastid diseases: single agents for Chagas and HAT.” Dr Baell noted that collaborator Dr Matthew Piggott at the University of Western Australia (UWA) made important contributions to the project. “The UWA is one of several Universities that have joined forces with us to progress hit-to-lead medicinal chemistry in a difficult funding environment,” he said. “Dr Piggott leads the UWA effort and this has been outstandingly successful.” The Foundation support grants for collaborative exchange for work on neglected diseases with the GSK specialist R&D facility at Tres Cantos in Madrid. All projects supported by the Open Lab Foundation must contribute to research that helps discover new medicines for diseases of the developing world.

Dr. Baell has been with Monash Institute of Pharmaceutical Sciences (MIPS) since 2012. Before his appointment to the University, Dr. Baell was based at the Walter and Eliza Hall Institute where he played a central role in establishing and leading a first class medicinal chemistry group. He has a range of research interests including the discovery of new anti-parasitic compounds for the treatment of malaria and neglected diseases, the design and synthesis of peptidomimetics and the development of selection criteria for quality high-throughput screening.

Association Management Software  ::  Legal